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Abstract
Background: Guanylyl Cyclase C (GCC) signaling via uroguanylin (UGN) and guanylin activation is a critical mediator of
intestinal fluid homeostasis, intestinal cell proliferation/apoptosis, and tumorigenesis. As a mechanism for some of these
effects, we hypothesized that GCC signaling mediates regulation of intestinal barrier function.
Methodology/Principal Findings: Paracellular permeability of intestinal segments was assessed in wild type (WT) and GCC deficient
(GCC2/2) mice with and without lipopolysaccharide (LPS) challenge, as well as in UGN deficient (UGN2/2)m i c e .I F N c and myosin
light chain kinase (MLCK) levels were determined by real time PCR. Expression of tight junction proteins (TJPs), phosphorylation of
myosin II regulatory light chain (MLC), and STAT1 activation were examined in intestinal epithelial cells (IECs) and intestinal mucosa.
The permeability of Caco-2 and HT-29 IEC monolayers, grown on Transwell filters was determined in the absence and presence of
GCC RNA interference (RNAi). We found that intestinal permeability was increased in GCC2/2and UGN2/2mice compared to WT,
accompanied by increased IFNc levels, MLCK and STAT1 activation in IECs. LPS challenge promotes greater IFNc and STAT1
activation in IECs of GCC2/2mice compared to WT mice. Claudin-2 and JAM-A expression were reduced in GCC deficient intestine;
the level of phosphorylated MLC in IECs was significantly increased in GCC2/2 and UGN2/2 mice compared to WT. GCC
knockdown induced MLC phosphorylation, increased permeability in IEC monolayers under basal conditions, and enhanced TNFa
and IFNc-induced monolayer hyperpermeability.
Conclusions/Significance: GCC signaling plays a protective role in the integrity of the intestinal mucosal barrier by
regulating MLCK activation and TJ disassembly. GCC signaling activation may therefore represent a novel mechanism in
maintaining the small bowel barrier in response to injury.
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Introduction
Guanylyl cyclase C (GCC) is a transmembrane receptor for the
endogenous peptides guanylin (GN) and uroguanylin (UGN) and
for bacterial heat stable enterotoxin (ST) [1,2]. GCC signaling
plays a pivotal role in the regulation of intestinal fluid and
electrolyte homeostasis [3]. Activation of GCC leads to increased
intracellular cyclic GMP (cGMP) accumulation and activation of
the cystic fibrosis transmembrane conductance regulator. Activa-
tion in response to the superagonist ST results in secretory
diarrhea [4,5]. In addition, GCC signaling regulates the renewal of
the intestinal epithelium by restricting the proliferating cell cycle
and promoting the transition from proliferation to differentiation
along the crypt to villus axis [6,7]. Deregulated GCC action is
postulated to result in colorectal tumorigenesis and GCC
expression is used as marker for human colorectal cancer
metastases [8,9]. Cross talk between activation of GCC signaling
and c-src in colonic epithelial cells might also represent a feed-
forward mechanism of cancer cell proliferation and disease
progression in colorectal cancer [10]. Our group has reported
that activation of GCC signaling pathway protects intestinal
epithelial cells from acute radiation-induced apoptosis [11].
However, it remains unknown whether GCC directly mediates
the regulation of intestinal epithelial barrier function.
Barrier function is highly regulated by tight junction proteins
(TJPs), allowing the epithelium to control transmucosal perme-
ability to solutes, water, and electrolytes [12,13]. Amongst many
components of TJs, occludin, junction adhesion molecule A (JAM-
A), and claudins are membrane proteins that connect adjacent
cells and build the intestinal barrier [13,14]. Activation of
actomyosin contraction, as assessed by phosphorylation of the
myosin II regulatory light chain (MLC), regulates the assembly of
TJPs [15]. Increased MLC kinase (MLCK) activity has been
demonstrated to mediate intestinal epithelial barrier dysfunction
induced by tumor necrosis factor a (TNFa) and interferon c
(IFNc) [16,17,18]. Cytokine-induced STAT1 activation in IECs
mediates the onset of intestinal diseases [19,20]. Conversely,
depletion or pharmacological inhibition of epithelial MLCK
PLoS ONE | www.plosone.org 1 January 2011 | Volume 6 | Issue 1 | e16139protected mice from TNFa-dependent intestinal epithelial barrier
loss, and improved diarrheal symptoms [21].
Defects in intestinal barrier function have been implicated in the
pathogenesis of a number of intestinal diseases, such as sepsis,
inflammatory bowel disease (IBD) and irritable bowel syndrome
(IBS). In our current studies, employing GCC and GCC ligand
deficient mice, we demonstrate that GCC signaling is required for
the maintenance of homeostatic intestinal barrier function,
identifying a novel pathway as well as a new potential therapeutic
target for intestinal barrier dysfunction.
Results
Loss of GCC signaling increases paracelluar permeability
in small intestine
As previously shown [8,22,23], we confirmed GCC expression
throughout all intestinal segments. However, by qualitative immuno-
histochemistry, GCC was mainly expressed in IECs (Fig 1 A). We next
determined paracellular permeability of intestinal segments in
GCC2/2 and WT mice. We found that jejunal paracellular
permeability to FD4 was significantly higher in GCC2/2 mice
under basal conditions; this was not seen in ileum and colon (Fig 1 B,
C and D). Analyzing LY uptake into jejunal villi of live mice by
confocal microscopy, we consistently found that the integrity of jejunal
epithelia was disrupted in GCC2/2 mice, as shown by significantly
increased LY inside villi. This was not apparent in the ileum and colon
(Fig 1 E and data not shown). Together, these results demonstrate that
loss of GCC signaling in the jejunum leads to mucosal barrier
dysfunction. In addition,underbasal conditions, compensation for loss
of GCC precludes barrier defects in the ileum and colon.
GCC2/2 mice are predisposed to LPS-induced intestinal
injury
To further determine the function of GCC signaling in intestinal
barrier,we challenged wild type (GCC+/+)m i c ea n dG C C2/2mice
with a non-lethal dose of LPS (1 mg/kg), which has been reported to
cause a mild and reversible alteration in intestinal barrier function by
promoting bacterial translocation and cytokine secretion [24]. LPS
challenge (12 hr) did not increase permeability in the jejunum of
GCC+/+ mice or the already elevated permeability in GCC2/2
mice (Fig 1B); however, we found there was remarkably elevated
permeability in the ileum of both genotypes after 12-hr LPS challenge
and the increase was significantly higher in GCC2/2 mice
compared to baseline (Fig 1B & C). Consistently, a significantly
higher amount of bacteria translocated to mesenteric lymph nodes
(MLN) in GCC2/2 mice relative to GCC+/+ mice after 12-hr LPS
challenge (Fig 2A), demonstrating that loss of GCC leads to ileal
barrier dysfunction after LPS challenge; also, GCC2/2 mice
Figure 1. Loss of GCC signaling increases paracellular permeability in small intestine. A) GCC expression was detected in colon, ileum, and
jejunum by immunohistochemistry (IH), inset is a negative control (Neg); original magnification, 6400, bar=50 mm, n=5. B, C & D) Jejunal, ileal and
colonic paracellular permeability was determined using an everted gut sac in WT (GCC+/+) and GCC knock out (GCC2/2) mice with and without LPS
(1 mg/kg) challenge, n=10. E) Permeability to Lucifer Yellow (LY) was measured in jejunum from GCC+/+ and GCC2/2, n=5. Relative intensity was
determined by the ratio of LY intensity inside villi versus luminal side. Results are expressed as the mean 6 SEM.
doi:10.1371/journal.pone.0016139.g001
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WT mice (p,0.01, Fig 2 B). Furthermore, upon increasing the LPS
dose to 4 mg/kg, we found that 90% of the GCC2/2 mice did not
survive by 24 hrs after LPS challenge, (p,0.05, see Fig 2 C),
suggesting that loss of GCC leads to catastrophic intestinal barrier
failure and results in death due to LPS-induced sepsis.
Loss of GCC signaling increases MLC phosphorylation in
IECs and disrupts TJP assembly in small intestine
TJPs regulate intestinal paracellular permeability, controlling
the penetration of pathogens and allergens to the submucosa
[12,13]. We first studied an up-stream kinase of TJP assembly,
MLCK which can be viewed as a final common pathway of acute
tight junction regulation in response to a broad range of immune
and infectious stimuli [16,25]. We found that loss of GCC led to a
significantly increased cellular abundance of pMLC in IECs
detected by both immunoblot and immunofluorescence (Fig 3A &
B). Subsequently, immunoblotting demonstrated that JAM -A and
Claudin-2 were significantly reduced in jejunum from GCC2/2
mice (Fig 3C). We also found a consistently reduced JAM-A
abundance in GCC2/2 crypts using confocal immunofluores-
cence microscopy (Fig 3D). This indicates that GCC signaling
Figure 2. GCC2/2 mice are predisposed to lipopolysaccharide (LPS) induced intestinal injury. GCC+/+ and GCC2/2 mice were
challenged with LPS (1 mg/kg) for 12 hrs, and bacterial translocation in MLN (A) and percentage of body weight loss (%) (B) were determined, n=10.
C) Mortality of GCC2/2 mice was determined after 24 hr-LPS (4 mg/kg) challenge, n=16. Results are expressed as the mean 6 SEM.
doi:10.1371/journal.pone.0016139.g002
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JAM-A and claudin-2. Together, these data strongly suggest that
GCC signaling mediates regulation of intestinal barrier function
by regulation of TJP assembly.
Loss of UGN leads to increased paracellular permeability
in small intestine
To test whether the role of GCC in maintaining barrier function
was ligand-dependent, we studied permeability in the jejunum of
UGN2/2 mice. UGN2/2 mice are also relatively deficient in
GN [3]. We found that UGN2/2 mice demonstrated significant
jejunal barrier dysfunction characterized by increased paracellular
permeability and bacterial translocation to MLN along with
increased MLC phosphorylation under basal conditions (see
Fig 4A, B & C), suggesting that intestinal UGN and GN are also
required for intestinal barrier homeostasis.
LPS exaggerates cytokines production in GCC2/2
intestinal mucosa
To further pursue the mechanism of increased barrier
dysfunction in GCC2/2 mice, we measured levels of cytokines
in the circulation. We found that IFN-c as well as IL12p70, but
not TNFa, were significantly elevated in the peripheral circulation
in GCC2/2 mice at baseline (Fig 5A). Using quantitative PCR,
we found no significant difference between genotypes in IFNc or
TNFa levels in the small intestine at baseline. However, a non-
lethal dose of LPS significantly upregulated IFNc mRNA
expression in GCC2/2 mice, while TNFa levels were not
significantly different (Fig 5B & C). This suggests that GCC null
mice have a deregulated immune function, resulting in suscepti-
bility to LPS induced intestinal injury.
Loss of GCC signaling activates IFN-c:MLCK pathway in
IECs
Employing laser capture microdissection (LCM), we isolated
jejunal IECs. We found there was a dramatically elevated IFN-c
mRNA level in the IEC compartment in GCC2/2 mice at
baseline compared to wild type (Fig 6A). STAT1 activation is an
important mediator of IFN-c signaling, reflecting intestinal
mucosal immune response and inflammation [19,26]. Concomi-
tant with increased levels of IFN-c in IEC compartment,
immunohistochemistry results showed that there was increased
phosphorylated STAT1 (pSTAT1) staining in jejunal IECs which
was sparsely distributed in a patchy fashion (Fig 6B). After 12 hr-
LPS challenge, STAT1 activation in IECs was greatly increased
and exhibited a more pervasive distribution in GCC2/2 mice
Figure 3. Loss of GCC signaling increases MLC phosphorylation in IECs and disrupts TJP assembly in small intestine. Jejunal IECs were
isolated with EDTA, and total protein was extracted from jejunal IECs, A) MLC abundance and phosphorylated MLC (pMLC) were measured by
Western blot, densitometry results normalized to total MLC, n=5. B) pMLC distribution was determined with immunofluorescence; dotted lines
encircle staining of pMLC, n=5. C) Total protein was extracted from jejunal tissue, and JAM-A and Claudin-2 abundance was determined by Western
blot, n=5. D) JAM-A distribution was determined with immunofluorescence, n=5, original magnification, 6400, bar=50 mm. Signal intensity was
determined by densitometry. Quantitated western blot results are shown as the mean 6 SEM. * p,0.05 versus GCC+/+ mice.
doi:10.1371/journal.pone.0016139.g003
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quantitative counting of pSTAT1 in villus IECs (Fig 6B).
Interestingly, flow cytometry analysis indicated that CD3
+ intra-
epithelial lymphocytes (IEL) were significantly increased in the
intestinal epithelial compartment of GCC2/2 mice (1.8560.15%
in WT versus 2.8660.4% in GCC2/2 mice, p,0.01, n=7); we
Figure 4. Loss of uroguanylin leads to increased paracelluar permeability in small intestine. Jejunal paracellular permeability was
determined by assessing flux of FD4 with an everted gut sac (A) and bacterial translocation in mesenteric lymph nodes (MLNs) (B) in WT (UGN+/+)
and uroguanylin deficient mice (UGN2/2), n=10. Jejunal IECs were isolated with EDTA, C) Myosin light chain (MLC) abundance and phosphorylated
MLC (pMLC) were measured with WB, densitometry results normalized to total MLC, n=4. Results are expressed as the mean 6 SEM. * p,0.05 versus
GCC+/+ mice.
doi:10.1371/journal.pone.0016139.g004
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LPS-treated GCC2/2 (Arrows, Fig 6B). These data suggest that
jejunal epithelial barrier has been severely damaged in GCC2/2
mice, and the infiltrated CD3
+ IELs might be the resource of
elevated IFNc in IEC compartment. As IFN-c primes intestinal
epithelia to respond to TNF-a and LIGHT which are associated
with induction of the epithelial (long) isoform of MLCK [18,27],
we employed real time PCR to quantitate levels of expression in
wild type and GCC2/2 mice. We found long MLCK mRNA
levels were significantly up regulated in GCC deficient jejunum at
Figure 5. LPS exaggerates cytokine production in GCC2/2 intestinal mucosa. A) Levels of IFNc, IL12p70, and TNFa were determined in the
circulation, using Bioplex
TM, n=8. B & C) TNFa and IFN-c mRNA levels were determined by real-time PCR in jejunal tissue either under basal condition
or following LPS challenge, n=6. Results are shown as the mean 6 SEM.
doi:10.1371/journal.pone.0016139.g005
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in GCC2/2 mice. Together, GCC may mediate the regulation
of IEC barrier specifically through an IFN-c:MLCK pathway.
Reduction of GCC signaling leads to hyperpermeability in
IEC monolayer
We grew HT-29 IEC monolayers on Transwell filters and used
RNA interference to achieve approximately 70% knockdown of
GCC expression. We observed that paracellular permeability in
post-confluent HT-29 cell monolayers, assessed by the apical-to-
basolateral flux of FD4, was markedly increased by knocking down
GCC expression (Figure S1, p=0.02). Consistently, TEER was
also reduced in GCC knock-down monolayers, compared to
transfection reagent control without siRNA (p=0.006, see Figure
S2). Similar results were obtained using the Caco-2 intestinal cell
line as well (Fig 7 and data not shown). These data indicate that
IEC monolayer permeability could be increased by inhibiting
GCC expression in vitro, analogous to results obtained with the
GC-C knockout mouse.
Reduction of GCC signaling up regulates MLC
phosphorylation and decreases TJPs in IEC monolayer
To mimic in vivo studies, we combined IFNc (10 ng/ml) with
TNFa (10 ng/ml) to stimulate the Caco-2 monolayers for 48 hr
[17]. Monolayer hyperpermeability, induced by cytokines, was
significantly enhanced by GCC knock-down compared to
cytokine-treated controls (p,0.01, Fig 7A). We next examined
MLC phosphorylation and the abundance of TJPs in Caco-2
monolayers after GCC knock down. TNFa and IFNc cause TJ
disruption and epithelial barrier loss by activating MLCK [17,18].
We first measured pMLC and found that pMLC was upregulated
by GCC knock down, which was further enhanced by IFNc and
TNFa treatment compared to controls (Fig 7B). We then found
that JAM-A and Claudin-2, membrane-associated TJPs, were
significantly reduced in IEC monolayers with GCC knock down;
this was potentiated by IFNc and TNFa administration (Fig 7B).
Interestingly, we did not find apparent alterations of other
components of TJPs, for example, claudin-1. Taken together,
these data further indicate that GCC signaling may mediate
regulation of intestinal epithelial barrier function directly through
affecting TJP assembly.
Discussion
Original descriptions of GCC null mice were marked by a
paradoxical lack of an obvious phenotype and we and others
suggested that the function of GCC would only be revealed by
systemic study and perturbation of gastrointestinal function [4,28].
This led to the establishment of roles for GCC in regulation of IEC
proliferation, apoptosis, and migration [6,9,11]. Epithelial barrier
function is a crucial component of gut homeostasis, and
dysregulation contributes to the pathogenesis of many intestinal
diseases. In this paper, we have shown that jejunal permeability
was increased in GCC2/2 and UGN2/2 mice compared to
WT. GCC2/2 mice exhibited ileal hyperpermeability and
greater bacterial translocation after LPS challenge, accompanied
by increased IFNc levels. The level of phosphorylated MLC in
IEC was significantly increased in GCC2/2 and UGN2/2
mice compared to WT; Claudin-2 and JAM-A expression in TJs
were reduced in GCC deficient IEC. GCC knockdown in IEC
monolayers was associated with increased permeability under
basal conditions and enhanced IFNc induced hyperpermeability
in IEC monolayers. Our data strongly suggest that GCC signaling
plays a role in the integrity of the intestinal mucosal barrier by
regulating epithelial MLC phosphorylation and TJ assembly.
Functional TJP strands are located between polarized epithelial
cells and characterize highly-differentiated gastrointestinal epithe-
lial cells [29]. GCC is highly expressed in differentiated
enterocytes. Waldman and co-workers have shown that loss of
GCC is associated with changes in IEC homeostasis, including
increased proliferation in the crypt, increased migration along the
crypt-villus axis, and increased apoptosis [6,9,30]. The magnitude
of these differences decreased from duodenum to colon and
parallels the level of hyperpermeability that we saw in different
segments of the intestinal tract, with highest disruption of barrier
function in the jejunum. It is possible that the changes in barrier
function and TJPs that we observed may contribute at least
partially to the alteration of homeostatic processes in GCC2/2
intestine. Dedifferentiated IECs can lead to immature production
of TJPs, and loss of contact inhibition [31]. Our results show that
loss of GCC signaling reduced JAM-A and Claudin-2 in vivo and
vitro, which have been determined to be associated with tumor
progression [32,33]. Most recently, GCC activation was found a
polar pattern of the effects on ion transport; GCC mucosal
activation resulted in a potent cGMP-chloride secretion, which
may add to its role in the intestinal barrier [34].
GN and UGN are expressed in the highly-differentiated
compartment along the crypt-villus axis, associated with the
transition from proliferation to differentiation [35]. They exhibit a
gradient of expression along the length of the gastrointestinal tract
with UGN levels highest in the proximal intestine and GN levels
highest in the colon [3]. Consistently, we found that UGN2/2
mice, which also exhibit a significant decrease in intestinal GN
protein [3], had a dysfunctional jejunal barrier function at
baseline. Together, this suggests that intestinal UGN and GN as
well as their signaling via GCC are required for the maintenance
of small bowel barrier function. Levels of cGMP are reduced by
50–75% in the intestines of both GC-C2/2 and UGN2/2 mice
[3,11] and this reduction may provide a basis for loss of TJ
function that remains to be investigated.
IFN-c selectively increases epithelial permeability to large
molecules by direct alteration of TJP assembly [36,37]. STAT-1
is an important signaling molecule for IFN-c; and STAT1
activation in IECs leads to downstream proinflammatory gene
expression, predisposing IECs to injury [38,39]. In our studies, we
found that GCC signaling is involved in a complicated modulation
of gut mucosal immunity. An increased level of cytokines (IFNc
and IL12p70) was detected in GCC knock out mice at baseline
accompanied by significantly elevated jejunal permeability,
MLCK expression and STAT1 activation in IECs. An important
mechanism through which IFNc drives barrier dysfunction is by
increasing expression of TNF and LIGHT receptors on epithelial
Figure 6. Loss of GCC signaling activates IFN-c:MLCK pathway in IECs. A) Jejunal IECs were captured by LCM, RNA isolated and the level of
IFNc mRNA was assessed by real-time PCR. n=7. B) Paraffin-embedded jejunal tissue was immunostained by pSTAT1, n=5, original magnification,
6400, bar=50 mm. pSTAT1 positive cells were counted by a semi-quantitative method and expressed as average positive cells per villus. Arrows
indicate pSTAT1 staining of intraepithelial lymphocytes in tissue from GCC2/2 mice. C) Long MLCK mRNA levels were determined by real-time PCR
in jejunal tissue either under basal condition or following LPS challenge, n=6. Results are shown as the mean 6 SEM. * p,0.05 versus WT group;
# p,0.05 versus LPS treated WT group and ‘ versus LPS treated GCC2/2 group.
doi:10.1371/journal.pone.0016139.g006
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[17,18]. Low dose LPS challenge resulted in a further disruption of
barrier function in the ileum of GCC null mice along with
significantly elevated luminal bacterial translocation. The barrier
dysfunction predisposed GCC null mice to LPS induced sepsis and
organ dysfunction, and subsequently resulted in increased
mortality upon high dose LPS challenge. Our data also indicated
that IFNc mRNA expression and IELs was elevated in LCM-
captured jejunal IEC compartment, suggesting that intestinal
barrier dysfunction in GCC deficient mice is maintained by a
continuous immune activation. These data indicates that loss of
GCC signaling may lead to a dysregulation of the mucosal
immune system, and triggers intestinal barrier dysfunction and
immune activation.
Primary pathophysiologically relevant intestinal epithelial bar-
rier dysfunction can broadly activate mucosal immune responses
and accelerate the onset and severity of immune-mediated colitis,
but is not sufficient for intestinal disease [25,40]. Cytokine-induced
epithelial barrier dysfunction can be mediated by increased
MLCK expression and subsequent myosin II regulatory light
chain (MLC) phosphorylation; TNFa, IFNc, and LIGHT (a
member of the TNFa superfamily) can cause MLCK-dependent
barrier dysfunction [21,41]. Furthermore, MLCK upregulation is
correlated with IBD disease activity, also suggesting that it may
contribute to barrier dysfunction in intestinal disease [16]. Our
data confirmed that loss of GCC signaling led to increased MLC
phosphorylation, MLCK mRNA expression and IEC barrier
dysfunction in mice. In comparison, our GCC knockdown studies
in IEC monolayers highlight an increase in permeability
accompanied by increased phosphorylation of MLC due only to
decreased levels of GCC. However, the manner in which GCC
signaling mediates the regulation of MLCK activity needs to be
explored in the future. Together, loss of GCC signaling leads to
the activation of IFN-c:MLCK pathway in IECs and may be an
important initiating event that leads to barrier dysfunction,
followed by pro-inflammatory factor production and a predispo-
sition to LPS-induced injury.
We found that reduced JAM-A and Claudin-2 abundance was
consistently associated with loss of GCC in both GCC deficient
mice and in GCC knock down IEC monolayers. JAM-A has been
demonstrated to regulate junctional assembly through recruiting
and binding these proteins to its intracellular C-terminus in order
to colocalize junctional proteins with the nascent junctions [42].
JAM-A null mice exhibit increased intestinal mucosal permeabil-
ity, and JAM-A has been determined to regulate epithelial
permeability, inflammation, and proliferation [43]. Aberrant
expression of Claudin-2 has been linked to SAMP1/YitFc (SAMP)
mice, that develop chronic ileitis [44]. Claudin-2 can convert
‘‘tight’’ tight junctions into leaky ones, and it was identified as a
cation-selective paracellular channel [45]. Upregulation of pore-
forming claudin 2 leads to altered tight junction structure and
pronounced barrier dysfunction in mild to moderately active
Crohn’s disease [46]. Conversely, reduced levels of claudin-2 or
JAM-A may also lead to disrupted barrier function [36].
Therefore, GCC signaling may be relevant to regulation of
intestinal barrier function directly through interacting with TJPs.
The precise mechanisms elucidating how GCC signaling is
involved in the regulation of TJPs is the basis for ongoing
investigation.
Disruption of intestinal barrier function leading to mucosal
inflammation and immune activation may be a key factor in the
pathogenesis of several diseases, including sepsis, IBD and IBS
[47,48,49]. IBS is characterized by an increased small bowel
paracellular permeability and an increased load of luminal
bacteria [48]. Linaclotide (MD-1100), a GCC agonist, has been
shown in animal studies to stimulate intestinal fluid secretion and
transit, but not in GCC null mice [50,51]. Linaclotide improved
bowel habits and symptoms of IBS patients with chronic
constipation although the mechanisms of action downstream of
cGMP are uncertain [51]. Our studies for the first time identify a
novel GCC:MLCK:TJP pathway that regulates intestinal barrier
function. Therefore, augmenting intestinal GCC activation may




All chemicals and antibodies were purchased from Sigma-
Aldrich (St. Louis, MO) unless otherwise noted. Antibodies specific
for MLC and phosphorylated MLC (serine 19) (pMLC) and
STAT1 (pSTAT1) were from Cell Signaling Technology (Dan-
vers, MA). Antibodies specific for JAM-A, Claudin 1, and 2 were
from Zymed (Carlsbad, CA). Antibody for GCC was from
FabGennix (Frisco, TX). ON-TARGET plus SMARTpool for
human GUCY2C was purchased from DHARMACON (Chicago,
IL).
Animal resources and maintenance
Animal studies were approved by the Cincinnati Children’s
Research Foundation (CCRF) Institutional Animal Care and Use
Committee (Protocol # 8E03019). GCC and UGN deficient mice
(GCC2/2 and UGN2/2) have previously been described
[3,28]. Mice were inbred for 10 generations to C57BL/6 and
maintained in specific pathogen free conditions. To induce a
systemic inflammatory response, mice were injected intraperito-
neally with Escherichia coli (strain O111:B4, Sigma) lipopolysaccha-
Table 1. PCR Primers.
Primers Sequences
b actin Forward: 59- CCCTAAGGCCAACCGTGAA -39
Reverse: 59- CAGCCTGGATGGCTACGTACA -39
TNFa Forward: 59 - AATGGCCTCCCTCTCATCAGTT - 39
Reverse: 59 – CCACTTGGTGGTTTGCTACGA - 39
IFNc Forward: 59 - GGCTGTCCCTGAAAGAAAGC - 39
Reverse: 59 - GAGCGAGTTATTTGTCATTCGG - 39
Long MLCK Forward: 59 - AAGTCATGGATGGAAGCCAGGTCA- 39
Reverse: 59 - AATCTCATTCCCGTCGTGAAGCCA- 39
doi:10.1371/journal.pone.0016139.t001
Figure 7. Reduction of GCC signaling decreases membrane-associated TJPs in IEC monolayer. A) Paracellular permeability in post-
confluent Caco-2 cell monolayers was assessed by TEER in the presence or absence of GCC siRNA, and IFNc (10 ng/ml) and TNFa (10 ng/ml), * p,0.01
versus TRAN (transfection reagents only) and
# p,0.01 versus IFNc and TNFa treated control cells, n=5. Results are shown as the mean 6 SEM. B)
Total protein was extracted from post-confluent Caco-2 cell monolayers with and without IFNc (10 ng/ml) and TNFa (10 ng/ml) treatment. JAM-A,
Claudin-1 & 2, MLC, and pMLC were assessed by Western blot, signal intensity was determined by densitometry. Results representative of five
independent experiments are shown and quantitated western blot results are expressed as the mean 6 SEM.
doi:10.1371/journal.pone.0016139.g007
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saline (PBS). Groups of mice were sacrificed 12 hrs after injection
of LPS for intestinal permeability assay or 24 hrs after injection for
survival study [24].
Measurement of paracellular intestinal permeability and
bacterial translocation
Jejunal, ileal and colonic paracellular permeability to the
fluorescent tracer fluorescein isothiocyanate-dextran with a
molecular mass of 4,000 Da (FD-4) was determined using an
everted gut sac method [52]. Fluorescence was measured using a
fluorescence spectrophotometer (Biotek Instruments, VT) at an
excitation wavelength of 492 and an emission wavelength of
515 nm. Permeability was expressed as the mucosal-to-serosal
clearance of FD-4. Bacterial translocation to mesenteric lymph
nude (MLN) was determined as previously described [52].
In vivo measure of local villus permeability
Methods are based on those described previously [53,54].
Briefly, after anesthesia, ,1 cm of jejunum was exteriorized, slit
open, and the mucosal surface rinsed with saline. Cell nuclei were
stained with Hoechst 33342 (2 mg/kg bw. Invitrogen, Eugene
OR) and imaged with 2-photon microscopy (Zeiss LSM510 NLO,
Jena Germany). Jejunal permeability was monitored by adding
50 mM Lucifer Yellow (LY; CH lithium salt, Molecular Probes) to
the superfusate, and confocal fluorescence imaging (458 nm
excitation, 505 nm emission). Post-acquisition image analysis used
Metamorph 7 (Molecular Devices, Downingtown, PA) and ImageJ
(NIH, Bethesda, MD). The intensity of luminal and tissue LY
fluorescence was measured in appropriate regions and expressed
as the tissue/lumen ratio.
Immunoblotting (IB), Immunohistochemistry (IH) and
immunofluorescence (IF)
Isolated jejunal IECs, jejunal tissue as well as cultured cells were
saved. Total cellular protein extracts and cytosolic protein were
prepared using cold RIPA buffer and the NE-PER kit per the
manufacturers’ recommendations (Pierce, Rockford, IL). Expression of
claudin1 & 2, junction adhesion molecule (JAM-A) and MLC, and
pMLC abundance were detected in total protein and in isolated jejunal
IECs. Band intensities were quantified as mean area density using
ImageQuant (Molecular Dynamics, Sunnyvale, CA). pMLC was
expressed as relative area density corrected by MLC bands intensity.
Frozen tissue sections from mouse jejunum (4 mm) were prefixed in
paraformaldehyde. Tissue sections were labeled with pMLC and JAM-
A. 49,6-diamidino-2-phenylindole dihydrochloride (DAPI) was used for
nuclear counterstaining following FITC-conjugated or TRITC-
conjugated goat anti-rabbit secondary antibodies. GCC expression
and phosphorylation of STAT1 were examined in paraffin embedded
intestinal sections using VECTASTAIN Elite ABC system (Vector lab,
Burlingame, CA). pSTAT1 positive cells were counted by a semi-
quantitative method and expressed as average positive cells per villus.
Images were captured using a Zeiss microscope and Axioviewer image
analysis software (Deutschland, Carl Zeiss Corp, Germany) [52,55].
Laser Capture Microdissection (LCM)
Briefly, approximately 200 crypts and adjacent surface epithelial
cells from jejunum were captured by a Veritas Microdissection
System (Molecular Devices, CA); RNA was isolated with a
PicoPure RNA Isolation kit (Arcturus) using our published
methods [55,56]. The quality and concentration of RNA was
measured by NanoDrop (Thermo Fisher). Total RNA (200 ng)
was used to reversely transcribe to cDNA followed by a SYBR
Green real-time PCR on the Mx4000 multiplex quantitative PCR
instrument (Stratagene).
Real-time PCR
Total RNA was isolated from frozen tissue using Tri Reagent
(Molecular Research Center, Inc., Cincinnati, OH) according to
the manufacturer’s protocol. RNA samples were treated with
DNase I (Ambion, Austin, TX) and reverse-transcribed (2 mg)
using random decamers (RETROscript, Ambion). PCR reactions
using specific gene primers were performed with Brilliant II SYBR
Green QPCR mix (Stratagene, La Jolla, CA) in the Mx3000p
thermocycler (Stratagene). A relative amount for each gene
examined was obtained from a standard curve generated by
plotting the cycle threshold value against the concentration of a
serially diluted RNA sample expressing the gene of interest. This
amount was normalized to the level of b actin RNA. Primer
sequences [57,58] are listed in the Table 1.
RNA interference and IEC monolayer permeability assay
[59,60]
GUCY2C ON-TARGETplus SMARTpool (Chicago, IL) trans-
fection was performed with pre-confluent HT-29 and Caco-2 cells
growing on Trans-well inserts (Becton Dickinson, Bedford, MA)
according to manufacturer’s instructions. Groups with transfection
reagents only (TRAN) were chosen as controls for RNA
interference. For subsequent experiments we used monolayers of
Caco-2 or HT-29 cells (21 days post-confluent). The medium
bathing the apical surface of the monolayers was replaced with
200 mL of DMEM complete medium containing FITC-Dextran
(FD-4, Sigma) at 25 mg/mL. The medium bathing the basolateral
surface was replaced with 500 mL of DMEM complete medium
alone or DMEM supplemented with or without IFNc (10 ng/ml)
and TNFa (10 ng/ml). Fluorescence in basolateral bathing
medium was measured using a fluorescence spectrophotometer
(Biotek Instruments, VT). The permeability of the monolayer was
expressed as a clearance (C; nl?cm
22?h
21). Transepithelial
electrical resistance (TEER) was measured by E-VOM instrument




Blood was directly collected from heart through diaphragm and




Briefly, mouse jejunum was everted and incubated in calcium-
magnesium-free HBSS with 1 mM EDTA for 30 minutes at 37uC
with gentle shaking to liberate IEC. Cell survival was determined
with an Annexin V kit (eBioscience). CD3-/7-AAD- (eBiosciences)
was used as a marker for intra-epithelial T lymphocytes. Data were
analyzed using FlowJo software.
Statistical Analysis
Results are presented as the mean 6 SEM. Data were analyzed
using analysis of variance, 2-tailed Student’s t test, and the Mann-
Whitney test as appropriate (Prism, GraphPad, San Diego, CA). P
values#0.05 were considered significant.
Supporting Information
Figure S1 Reduction of GCC signaling leads to hyper-
permeability in IEC monolayer. HT-29 IEC monolayers
Guanylyl Cyclase C Signaling in Intestine
PLoS ONE | www.plosone.org 11 January 2011 | Volume 6 | Issue 1 | e16139were grown on Transwell filters. Paracellular permeability in post-
confluent HT-29 cell monolayers was assessed by the apical-to-
basolateral flux of FD4 in the presence and absence of GCC
siRNA, n=5. Results are shown as the mean 6 SEM.
(TIF)
Figure S2 Reduction of GCC signaling leads to hyper-
permeability in IEC monolayer. HT-29 IEC monolayers
were grown on Transwell filters. Paracellular permeability in post-
confluent HT-29 cell monolayers was assessed by TEER in the
presence and absence of GCC siRNA, n=5. Results are shown as
the mean 6 SEM.
(TIF)
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